title: Toward a Broader View of Ube3a in a Mouse Model of Angelman Syndrome: Expression in Brain, Spinal Cord, Sciatic Nerve and Glial Cells.
abstract: Angelman Syndrome (AS) is a devastating neurodevelopmental disorder characterized by developmental delay, speech impairment, movement disorder, sleep disorders and refractory epilepsy. AS is caused by loss of the Ube3a protein encoded for by the imprinted Ube3a gene. Ube3a is expressed nearly exclusively from the maternal chromosome in mature neurons. While imprinting in neurons of the brain has been well described, the imprinting and expression of Ube3a in other neural tissues remains relatively unexplored. Moreover, given the overwhelming deficits in brain function in AS patients, the possibility of disrupted Ube3a expression in the infratentorial nervous system and its consequent disability have been largely ignored. We evaluated the imprinting status of Ube3a in the spinal cord and sciatic nerve and show that it is also imprinted in these neural tissues. Furthermore, a growing body of clinical and radiological evidence has suggested that myelin dysfunction may contribute to morbidity in many neurodevelopmental syndromes. However, findings regarding Ube3a expression in non-neuronal cells of the brain have varied. Utilizing enriched primary cultures of oligodendrocytes and astrocytes, we show that Ube3a is expressed, but not imprinted in these cell types. Unlike many other neurodevelopmental disorders, AS symptoms do not become apparent until roughly 6 to 12 months of age. To determine the temporal expression pattern and silencing, we analyzed Ube3a expression in AS mice at several time points. We confirm relaxed imprinting of Ube3a in neurons of the postnatal developing cortex, but not in structures in which neurogenesis and migration are more complete. This furthers the hypothesis that the apparently normal window of development in AS patients is supported by an incompletely silenced paternal allele in developing neurons, resulting in a relative preservation of Ube3a expression during this crucial epoch of early development.
authors.affiliation: Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37232-8552, United States of America.
authors.forename: Mark D
authors.initials: MD
authors.lastname: Grier
authors.affiliation: Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37232-8552, United States of America; Department of Pediatrics, Vanderbilt University Medical Center, Nashville TN 37232-8552, United States of America.
authors.forename: Robert P
authors.initials: RP
authors.lastname: Carson
authors.affiliation: Department of Neurology, Vanderbilt University Medical Center, Nashville, TN 37232-8552, United States of America; Department of Neurology, Tennessee Valley Veterans Administration, Nashville, TN 37212, United States of America.
authors.forename: Andre Hollis
authors.initials: AH
authors.lastname: Lagrange
mesh_terms: D000483:Alleles; D017204:Angelman Syndrome / Q000378:metabolism*; D000818:Animals; D001253:Astrocytes / Q000378:metabolism; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D002457:Cell Extracts; D002478:Cells, Cultured; D004195:Disease Models, Animal; D005260:Female; D020868:Gene Silencing; D018392:Genomic Imprinting; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009457:Neuroglia / Q000378:metabolism* / Q000473:pathology; D009836:Oligodendroglia / Q000378:metabolism; D012584:Sciatic Nerve / Q000378:metabolism* / Q000473:pathology; D013116:Spinal Cord / Q000378:metabolism* / Q000473:pathology; D013997:Time Factors; D044767:Ubiquitin-Protein Ligases / Q000378:metabolism*
chemical_list: D002457:Cell Extracts; C502429:Ube3a protein, mouse; D044767:Ubiquitin-Protein Ligases